Skip to main content
Top
Published in: Pediatric Surgery International 4/2006

01-04-2006 | Original Article

Colchicine in experimental alkaline burns of the rat esophagus: an old drug, a new indication?

Authors: Vahit Yukselen, Enver Vardar, Ozden Yukselen, Ali Onder Karaoglu, Cigdem Yenisey, Omer Ozutemiz

Published in: Pediatric Surgery International | Issue 4/2006

Login to get access

Abstract

Aim: An experimental study was performed to investigate the efficacy of colchicine in the prevention of fibrosis in the alkaline burn of the esophagus in rats. Method: A standard esophageal alkaline burn was produced by the application of 37.5% NaOH for a period of 90 s to the distal esophagus followed by a water rinse. The experiments were conducted twice with two different dosages of colchicine. In the first experiment, colchicine 1 mg/kg (i.p.) was applied once, on the first day. Group A (n:8), the sham laparotomy group; group B (n:8), the untreated group (positive control group); Group C (n:16), where the standard esophageal burn was induced and colchicine applied at a dose of 1 mg/kg i.p. in 1 ml volume, and group D (n:14), where the rats did not have any operation, but were treated with colchicine (1 mg/kg, i.p.) as in group C. In the second experiment, colchicine was applied at repeated doses of 100 μg/kg (i.p.) on the first, 7th, 14th, and 21st days. Twenty-five rats were divided into groups. Group AA (n:8), the sham laparotomy group; group BB (n:9), the untreated group (positive control group); and group CC (n:8), where the standard esophageal burn was induced and colchicine was applied at repeated doses. All the rats were killed on the 28th day and evaluated for esophageal tissue hydroxyproline content and histopathologic damage score. Results: Colchicine treatment at a dose of 1 mg/kg significantly reduced the quantity of hydroxyproline in the esophageal tissue in groups C and D compared with the positive control group B (P<0.05). However, it is associated with a mortality rate of 60%. Colchicine at repeated doses of 100 μg/kg showed no significant effect in group CC compared to the untreated group BB and in the quantity tissue of hydroxyproline content (P>0.05). Conclusion: At non-toxic doses, colchicine was not effective in the treatment of alkaline esophageal burn in rats. Colchicine-like molecules with less adverse effects or colchicine itself in titrated doses may be hopeful in preventing the development of fibrosis in the alkaline burns of the esophagus.
Literature
1.
go back to reference Zhang L, Zhu Y, Luo W et al (1992) The protective effect of colchicine on bleomycine-induced pulmonary fibrosis in rats. Chin Med Sci J 7:58–60PubMed Zhang L, Zhu Y, Luo W et al (1992) The protective effect of colchicine on bleomycine-induced pulmonary fibrosis in rats. Chin Med Sci J 7:58–60PubMed
2.
go back to reference Rao VC, Mehendale HM (1993) Effect of antimitotic agent colchicine on carbon tetrachloride toxicity. Arch Toxicol 67:392–400CrossRefPubMed Rao VC, Mehendale HM (1993) Effect of antimitotic agent colchicine on carbon tetrachloride toxicity. Arch Toxicol 67:392–400CrossRefPubMed
3.
go back to reference Sobh M, Sabry A, Moustafa F et al (1998) Effect of colchicines on chronic ciclosporin nephrotoxicity in Sprague-Dawley rats. Nephron 79:452–457CrossRefPubMed Sobh M, Sabry A, Moustafa F et al (1998) Effect of colchicines on chronic ciclosporin nephrotoxicity in Sprague-Dawley rats. Nephron 79:452–457CrossRefPubMed
4.
go back to reference Entzian P, Schlaak M, Seitzer U et al (1997) Antiinflammatory and antifibrotic properties of colchicines: implications for idiopathic pulmonary fibrosis. Lung 175:41–51PubMedCrossRef Entzian P, Schlaak M, Seitzer U et al (1997) Antiinflammatory and antifibrotic properties of colchicines: implications for idiopathic pulmonary fibrosis. Lung 175:41–51PubMedCrossRef
5.
go back to reference Selman M, Carrillo G, Salas J et al (1998) Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial. Chest 114:507–512PubMedCrossRef Selman M, Carrillo G, Salas J et al (1998) Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial. Chest 114:507–512PubMedCrossRef
6.
go back to reference Addrizzo-Harris DJ, Harkin TJ, Tchou-Wong KM et al (2002) Mechanisms of colchicine effect in the treatment of asbestosis and idiopathic pulmonary fibrosis. Lung 180:61–72CrossRefPubMed Addrizzo-Harris DJ, Harkin TJ, Tchou-Wong KM et al (2002) Mechanisms of colchicine effect in the treatment of asbestosis and idiopathic pulmonary fibrosis. Lung 180:61–72CrossRefPubMed
7.
go back to reference Rambaldi A, Gluud C (2001) Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis. Liver 21:129–136CrossRefPubMed Rambaldi A, Gluud C (2001) Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis. Liver 21:129–136CrossRefPubMed
8.
go back to reference Gehanno P, Guedon C (1981) Inhibition of experimental esophageal lye strictures by penicillamin. Arch Otolaryngol 107:145–147PubMed Gehanno P, Guedon C (1981) Inhibition of experimental esophageal lye strictures by penicillamin. Arch Otolaryngol 107:145–147PubMed
9.
go back to reference Rao VC, Mehendale HM (1991) Colchicine antimitosis abolishes CCl4 autoprotection. Toxicol Pathol 19:597–606PubMedCrossRef Rao VC, Mehendale HM (1991) Colchicine antimitosis abolishes CCl4 autoprotection. Toxicol Pathol 19:597–606PubMedCrossRef
10.
go back to reference Demirbilek S, Bernay F, Rızalar R et al (1994) Effects of estradiol and progesterone on the synthesis of collagen in corrosive esophageal burns in rats. J Pediatr Surg 29:1426–1428CrossRef Demirbilek S, Bernay F, Rızalar R et al (1994) Effects of estradiol and progesterone on the synthesis of collagen in corrosive esophageal burns in rats. J Pediatr Surg 29:1426–1428CrossRef
11.
go back to reference Reddy GK, Enwemeka CS (1996) A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29:225–229CrossRefPubMed Reddy GK, Enwemeka CS (1996) A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29:225–229CrossRefPubMed
12.
go back to reference Mery P, Riou B, Chemla D et al (1994) Cardiotoxicity of colchicines in the rat. Intensive Care Med 20:119–123CrossRefPubMed Mery P, Riou B, Chemla D et al (1994) Cardiotoxicity of colchicines in the rat. Intensive Care Med 20:119–123CrossRefPubMed
13.
go back to reference Dinsdale D (1975) Colchicine-induced lesions in the rat duodenum. Pathol Eur 10:95–104PubMed Dinsdale D (1975) Colchicine-induced lesions in the rat duodenum. Pathol Eur 10:95–104PubMed
14.
go back to reference Goldschmidt RB, Steward O (1989) Comparison of the neurotoxic effects of colchicines, the vinca alkaloids, and other microtubule poisons. Brain Res 486:133–140CrossRefPubMed Goldschmidt RB, Steward O (1989) Comparison of the neurotoxic effects of colchicines, the vinca alkaloids, and other microtubule poisons. Brain Res 486:133–140CrossRefPubMed
15.
go back to reference Thompson J (1987) Corrosive esophageal injuries. II. An investigation of treatment methods and histochemical analysis of esophageal strictures in a new animal model. Laryngoscope 97:1191–1202PubMed Thompson J (1987) Corrosive esophageal injuries. II. An investigation of treatment methods and histochemical analysis of esophageal strictures in a new animal model. Laryngoscope 97:1191–1202PubMed
16.
go back to reference Wang RY, Abrams T, Monfils P et al (1999) The effects of colchicines treatment on wound healing in a caustic murine injury model. Clin Toxicol 37:845–853CrossRef Wang RY, Abrams T, Monfils P et al (1999) The effects of colchicines treatment on wound healing in a caustic murine injury model. Clin Toxicol 37:845–853CrossRef
17.
go back to reference Poo LJ, Feldman G, Moreau A et al (1993) Early colchicines administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation. J Hepatol 19:90–94CrossRefPubMed Poo LJ, Feldman G, Moreau A et al (1993) Early colchicines administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation. J Hepatol 19:90–94CrossRefPubMed
18.
go back to reference Jiang Z, You DY, Chen XC et al (1992) Monitoring of serum markers for fibrosis during CCl4-induced liver damage, effects of antifibrotic agents. J Hepatol 16:282–289CrossRefPubMed Jiang Z, You DY, Chen XC et al (1992) Monitoring of serum markers for fibrosis during CCl4-induced liver damage, effects of antifibrotic agents. J Hepatol 16:282–289CrossRefPubMed
Metadata
Title
Colchicine in experimental alkaline burns of the rat esophagus: an old drug, a new indication?
Authors
Vahit Yukselen
Enver Vardar
Ozden Yukselen
Ali Onder Karaoglu
Cigdem Yenisey
Omer Ozutemiz
Publication date
01-04-2006
Publisher
Springer-Verlag
Published in
Pediatric Surgery International / Issue 4/2006
Print ISSN: 0179-0358
Electronic ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-006-1644-5

Other articles of this Issue 4/2006

Pediatric Surgery International 4/2006 Go to the issue